IAT Reinsurance’s AbbVie ABBV Stock Holding History

IAT Reinsurance’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$490K	Hold	1,948	–	–	0.29%	55
2026 Q1	$424K	Hold	1,948	–	–	0.14%	56
2025 Q4	$445K	Hold	1,948	–	–	0.13%	56
2025 Q3	$451K	Hold	1,948	–	–	0.1%	64
2025 Q2	$362K	Hold	1,948	–	–	0.08%	66
2025 Q1	$408K	Hold	1,948	–	–	0.09%	57
2024 Q4	$346K	Hold	1,948	–	–	0.07%	57
2024 Q3	$385K	Hold	1,948	–	–	0.09%	55
2024 Q2	$334K	Hold	1,948	–	–	0.07%	56
2024 Q1	$355K	Hold	1,948	–	–	0.16%	59
2023 Q4	$302K	Hold	1,948	–	–	0.06%	65
2023 Q3	$290K	Hold	1,948	–	–	0.06%	61
2023 Q2	$262K	Hold	1,948	–	–	0.05%	66
2023 Q1	$310K	Hold	1,948	–	–	0.06%	64
2022 Q4	$315K	Hold	1,948	–	–	0.06%	59
2022 Q3	$261K	Hold	1,948	–	–	0.05%	61
2022 Q2	$298K	Hold	1,948	–	–	0.05%	68
2022 Q1	$316K	Hold	1,948	–	–	0.02%	85
2021 Q4	$264K	Hold	1,948	–	–	0.04%	57
2021 Q3	$210K	Hold	1,948	–	–	0.03%	58
2021 Q2	$219K	Sell	1,948 -13,423	-87%	-$1.51M	0.03%	75
2021 Q1	$1.66M	Hold	15,371	–	–	0.25%	37
2020 Q4	$1.65M	Hold	15,371	–	–	0.34%	28
2020 Q3	$1.35M	Hold	15,371	–	–	0.33%	32
2020 Q2	$1.51M	Buy	+15,371	New	+$1.35M	0.41%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IAT Reinsurance's ABBV Position: Q2 2026 in Review

IAT Reinsurance held its AbbVie (ABBV) position steady in Q2 2026 at 1,948 shares worth $490K. The position accounts for 0.29% of the portfolio, ranked #55.

IAT Reinsurance first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.66M in Q1 2021. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

IAT Reinsurance held 1,948 shares of AbbVie worth $490K as of Q2 2026.
IAT Reinsurance left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.29% of IAT Reinsurance's portfolio in Q2 2026, its #55 holding.
IAT Reinsurance first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
IAT Reinsurance's AbbVie position peaked at $1.66M in Q1 2021.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IAT Reinsurance's 13F filing for Q2 2026, filed 13 Aug 2026.